Bandingkan Harga & Kinerja Eterindo Wahanatama Tbk (ETWA) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Eterindo Wahanatama Tbk dan UBC Medical Indonesia Tbk.: Eterindo Wahanatama Tbk diperdagangkan di Rp70 (kapitalisasi pasar 326,81 M), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Eterindo Wahanatama Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| ETWA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 326,81 M | 691,25 M |
Volume | — | 635,5 rb |
Lot | — | 6,36 rb |
Perputaran | — | 110,15 jt |
Harga Rata-rata | — | 173,33 |
Nilai Transaksi | — | 110,15 jt |
Harga Ekuilibrium Indikatif | — | 174 |
Volume Ekuilibrium Indikatif | — | 50 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Eterindo Wahanatama Tbk
PT Eterindo Wahanatama Tbk or Eterindo is the parent company to midstream specialty chemical companies, interrelated by ownership and through both vertical and horizontal integration. Eterindo has established itself as one of the largest producers of specialty in South East Asia. The products are used as raw material in the production of paints, coatings, adhesives and similar consumer product realm. The breadth of its range gives Eterindo a distinct edge over its competitors.Presently, Eterindo is among the largest producers of plasticizers, an important raw material for producing cables, footwear, tyres and other basic consumer goods, near to one daily usage in life. Modern production facilities, state of the art technology and a highly trained and dedicated labour force means Eterindo companies will continue to offer high quality at competitive prices, to customers at home and overseas. In recognition of its technical achievement, Eterindo has been awarded ISO 9002 certification. Strategic partnership have been formed with multinationals, including Mitsui & Co. Ltd. Of Japan, Kyowa Hakko Kogyo Co. Ltd., Mitsui Bussan Solvent & Coating Co., Ltd., Daewoo Group of Korea and state owned company PT Petrokimia Gresik.
Selengkapnya di halaman ETWA →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
